TheEdgeResearch
Home / Stocks / BUDZ

WEED, Inc. (BUDZ)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.03 ▲ +0.00%
Market Cap
$4.4M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.46
52-Wk Range
0.0159-0.0848
CEO
Glenn E. Martin
Country
US
Currency
USD

WEED, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Tucson, AZ, US. The stock last traded at $0.03, up 0.00% on the session, giving a market capitalisation of $4.4M. On trailing twelve-month figures it carries a trailing P/E of -3.57, a net margin of 0.0%. Its beta of 1.46 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.57
Price / Sales
0.00
Price / Book
-4.74
EV / EBITDA
-4.85
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-0.59
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2010-04-05
Headquarters
Tucson, AZ, US
About WEED, Inc.

Operating from its headquarters in Tucson, Arizona, WEED, Inc., along with its associated entities, is dedicated to the research, development, and practical application of cannabis-based compounds for therapeutic use in human diseases. The company, which was founded in 1999, officially adopted the name WEED, Inc. in February 2015, having previously been known as United Mines, Inc.

Comparable companies

WEED, Inc. is most often compared with the following Healthcare names:

AUSAFBBRRFBQSTCBIHCVSIDHBUFIONKFPCLOFTHCBFVDQSF
More research on BUDZ
BUDZ technical analysis BUDZ TheEdge Score Compare against peers
Open full interactive analysis & DCF →